News

ECHAlliance member Tunstall Statement about COVID-19

Published on: 18/03/2020

ECHAlliance member Tunstall Statement about COVID-19
Covid-19
Member News

We are committed to working with our customers and staff to minimise the effects of COVID-19 and continue to monitor the advice from Government. We have taken active steps aimed at business continuity in a pandemic situation.

We have further examined all areas of our business and supply chain to understand potential risk areas specific to COVID-19 and have considered the potential impacts. We continue to liaise with the TSA, and other industry partners, to have mitigating actions in place and we will continue to monitor the evolving nature of this situation.

Tunstall’s business continuity procedures have been developed to prioritise critical services delivery in circumstances where its workforce may be affected by widespread illness. This includes the dynamic redeployment of management and staff as circumstances dictate.

Staff continue to be advised to follow government and NHS guidance regarding travel declarations, self-isolation, the use of hand sanitiser, frequent hand washing, desk cleaning and personal hygiene.  In accordance with the latest advice from Government, we are combining normal workplace attendance with appropriate home working where possible.

This statement will be reviewed and updated as necessary as the advice from authorities (e.g. Chief Medical Officers, Foreign and Commonwealth Office and Public Health England) changes.

Tunstall Response

In addition to its existing business continuity plan, Tunstall Response has assembled a crisis team to manage the effects of the COVID-19 on service delivery. Their focus is to ensure the architecture, infrastructure, network and deployment at Tunstall Response is prepared for the possible effects of the COVID-19. This includes additional personnel, facilitating increased offsite working, training to increase calls handling capacity, and a reduction in non-essential activities.

Supply chain

Tunstall’s standard stocking policy is to hold six weeks of component buffer stocks either at our suppliers, or in house, where goods are manufactured by Tunstall in the UK.  In addition, buffers of finished goods are held at our Whitley site. Over the past weeks, we have been increasing our stock holding in the event we may need to mitigate against the effects of the COVID-19.

To date, there has been no adverse impact on our manufacturing plant, or on our ability to despatch orders, as a result of the COVID-19.

The current status of manufacturing in China is generally positive. All of Tunstall’s suppliers are operational again following the extended Lunar holiday period, albeit some with reduced capacity, and we are now receiving shipments from China. Likewise, we are not experiencing any shortages within the European supply chain at this time.

Next steps

Any changes to this position will be communicated as soon as possible.

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *